Call Anytime

+66 98-828-1773

At Dr. StemCellsThailand, we are dedicated to advancing the field of regenerative medicine through innovative cellular therapies and stem cell treatments. With over 20 years of experience, our expert team is committed to providing personalized care to patients from around the world, helping them achieve optimal health and vitality. We take pride in our ongoing research and development efforts, ensuring that our patients benefit from the latest advancements in stem cell technology. Our satisfied patients, who come from diverse backgrounds, testify to the transformative impact of our therapies on their lives, and we are here to support you on your journey to wellness.

Visiting Hours

Gallery Posts

Day: April 12, 2025

Constitutional symptoms (CS) refer to systemic changes that affect the overall health and well-being of an individual. In the context of lung cancer, these symptoms often manifest as the disease progresses and can include unexplained weight loss, fatigue, malaise, and fever. Below is a detailed overview of constitutional symptoms associated with lung cancer.

Constitutional Symptoms (CS)

Constitutional symptoms (CS) refer to systemic changes that affect the overall health and well-being of an individual. In the context of lung cancer, these symptoms often manifest as the disease progresses

Read More
Pancoast tumors (PCT) are a rare type of lung cancer located at the apex of the lung, typically involving the superior sulcus. They are characterized by their aggressive nature and invasion into nearby structures, leading to distinctive symptoms known as Pancoast syndrome. Below is a detailed overview of Pancoast tumors, including their symptoms, diagnosis, and treatment options.

Pancoast Tumors (PCT)

Pancoast tumors (PCT) are a rare type of lung cancer located at the apex of the lung, typically involving the superior sulcus. They are characterized by their aggressive nature and invasion

Read More
Large cell carcinoma (LCC) is a subtype of non-small cell lung cancer (NSCLC) characterized by its aggressive nature and rapid growth. It is a heterogeneous group of undifferentiated malignant neoplasms lacking specific features of other NSCLC subtypes like adenocarcinoma or squamous cell carcinoma. Below is a detailed overview of LCC, including its symptoms, diagnosis, and treatment options.

Large Cell Carcinoma (LCC)

Large cell carcinoma (LCC) is a subtype of non-small cell lung cancer (NSCLC) characterized by its aggressive nature and rapid growth. It is a heterogeneous group of undifferentiated malignant neoplasms lacking

Read More
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 85% of cases. It typically grows and spreads more slowly than small cell lung cancer (SCLC) but is often diagnosed at advanced stages due to its asymptomatic early course. Below is a detailed overview of NSCLC, including its subtypes, symptoms, risk factors, and treatment approaches.

Non-Small Cell Lung Cancer (NSCLC)

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 85% of cases. It typically grows and spreads more slowly than small cell lung cancer

Read More
Tyrosine kinase inhibitors (TKI) are a class of pharmaceuticals that block the activity of tyrosine kinases, enzymes critical for signaling pathways regulating cell growth, differentiation, and survival. By inhibiting these enzymes, TKIs disrupt abnormal signaling in diseases like cancer and inflammatory disorders. Below is a detailed overview of TKIs, including their mechanisms, therapeutic uses, and challenges.

Tyrosine Kinase Inhibitors (TKI)

Tyrosine kinase inhibitors (TKI) are a class of pharmaceuticals that block the activity of tyrosine kinases, enzymes critical for signaling pathways regulating cell growth, differentiation, and survival. By inhibiting these enzymes,

Read More